New combo shows promise in slowing advanced myeloma
NCT ID NCT03180736
First seen Jan 06, 2026 · Last updated May 01, 2026 · Updated 15 times
Summary
This study tested whether adding daratumumab to two standard drugs (pomalidomide and dexamethasone) could help people with multiple myeloma that came back or didn't respond to earlier treatments. 304 adults took part. The goal was to see if the triple combination could delay cancer growth longer than the two-drug regimen alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ancona
Ancona, Italy
-
Anticancer Hospital of Thessaloniki "Theageneio"
Thessaloniki, Greece
-
Antwerpen
Antwerp, Belgium
-
Badalona
Badalona, Spain
-
Barcelona
Barcelona, Spain
-
Belgrade
Belgrade, Serbia
-
Bologna
Bologna, Italy
-
Brescia
Brescia, Italy
-
Brno
Brno, Czechia
-
Brussel
Brussels, Belgium
-
Capa
Çapa, Turkey (Türkiye)
-
Cebeci
Cebeli, Turkey (Türkiye)
-
Doctor Peset University Hospital Medical Centre
Valencia, Spain
-
Erasmus MC
Rotterdam, Netherlands
-
Freiburg
Freiburg im Breisgau, Germany
-
Gaziantep
Gaziantep, Turkey (Türkiye)
-
General Hospital of Athens "Evangelismos"
Athens, Greece
-
General University Hospital of Patras
Pátrai, Greece
-
Hamburg
Hamburg, Germany
-
Heidelberg
Heidelberg, Germany
-
Hospital Quirón Salud Madrid
Madrid, Spain
-
Hospital Universitario de la Princesa
Madrid, Spain
-
Izmir
Izmir, Turkey (Türkiye)
-
Kayseri
Kayseri, Turkey (Türkiye)
-
Kiel
Kiel, Germany
-
Milano
Milan, Italy
-
Odense
Odense, Denmark
-
Ostrava
Ostrava, Czechia
-
Praha 2
Prague, Czechia
-
Roma
Roma, Italy
-
Salamanca University Hospital
Salamanca, Spain
-
Schwerin
Schwerin, Germany
-
Torino
Torino, Italy
-
Tübingen
Tübingen, Germany
-
UZ Gent
Ghent, Belgium
-
University of Athens School of Medicine
Athens, Greece
-
VU MC
Amsterdam, Netherlands
-
Vejle
Vejle, Denmark
-
Würzburg
Würzburg, Germany
-
Yvoir
Yvoir, Belgium
Conditions
Explore the condition pages connected to this study.